We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAR.PRE
526
DELISTED
iStar Inc.
STAR.PRE
$202K ﹤0.01%
+9,114
New +$190K
GLW icon
527
Corning
GLW
$132B
$201K ﹤0.01%
+9,642
New +$179K
AA icon
528
Alcoa
AA
$13.5B
$198K ﹤0.01%
8,614
+856
+11% +$17.4K
HPE icon
529
Hewlett Packard
HPE
$72B
$189K ﹤0.01%
+18,350
New +$154K
TXTR
530
DELISTED
TEXTURA CORPORATION COM
TXTR
$188K ﹤0.01%
+10,075
New +$169K
XPLR
531
DELISTED
Xplore Technologies Corp.
XPLR
$187K ﹤0.01%
53,541
GNMK
532
DELISTED
GenMark Diagnostics, Inc
GNMK
$174K ﹤0.01%
33,015
-1,512
-4% -$8.42K
SLV icon
533
iShares Silver Trust
SLV
$33.8B
$171K ﹤0.01%
+11,663
New +$166K
CSII
534
DELISTED
Cardiovascular Systems, Inc.
CSII
$159K ﹤0.01%
15,330
OXLC
535
Oxford Lane Capital
OXLC
$944M
$153K ﹤0.01%
3,630
RDN icon
536
Radian Group
RDN
$4.83B
$151K ﹤0.01%
12,206
HPQ icon
537
HP
HPQ
$27.1B
$141K ﹤0.01%
11,464
+1,257
+12% +$13.4K
RITM icon
538
Rithm Capital
RITM
$5.59B
$141K ﹤0.01%
12,136
USO icon
539
United States Oil Fund
USO
$2.03B
$132K ﹤0.01%
1,704
+172
+11% +$12.8K
AG icon
540
First Majestic Silver
AG
$10.7B
$126K ﹤0.01%
19,383
WEN icon
541
Wendy's
WEN
$1.49B
$109K ﹤0.01%
10,000
SCU
542
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$105K ﹤0.01%
2,410
-741
-24% -$34.9K
IMMU
543
DELISTED
Immunomedics Inc
IMMU
$104K ﹤0.01%
41,435
-120
-0.3% -$270
BDJ icon
544
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$100K ﹤0.01%
+13,226
New +$94.9K
ELI
545
DELISTED
ELITE PHARMACEUTICAL
ELI
$91K ﹤0.01%
293,180
FCFP
546
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$87K ﹤0.01%
10,000
SIRI icon
547
SiriusXM
SIRI
$9.61B
$76K ﹤0.01%
1,920
-1,067
-36% -$39.9K
UCTT
548
Ultra Clean Holdings
UCTT
$3.38B
$73K ﹤0.01%
13,601
SBS icon
549
Sabesp
SBS
$17B
$67K ﹤0.01%
+52,571
New +$55.6K
FTR
550
DELISTED
Frontier Communications Corp.
FTR
$64K ﹤0.01%
759
+71
+10% +$5.16K

Similar funds

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.